Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure

Journal of the American Geriatrics Society

Volumn 46, Issue 12, 1998, Pages 1550-1554

  Forman, Daniel E ^a,c   Chander, Ravi B ^b   Lapane, Kate L ^a   Shah, Parul ^a   Stoukides, John ^a  

^a BROWN UNIVERSITY   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL;

AGED; ARTICLE; DRUG USE; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PRESCRIPTION; RETROSPECTIVE STUDY;

EID: 0031770896     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01541.x     Document Type: Article

References (34)

1. US Bureau of the Census. Sixty-five Plus in America. Current Population Reports. Washington, DC: US Government Printing Office, 1992, pp 23-178.
2. Bonneaux L, Barendregt MA, Meeter K et al. Estimating clinical mortality due to ischemic heart disease and congestive heart failure: The future rise of heart failure. Am J Public Health 1994;84:20-28.
3. Wei JY. Age and the cardiovascular system. N Engl J Med 1992;327:1735-1739.
4. Graves EJ. National Hospital Discharge Survey: Annual Summary 1991. Washington, DC: National Center for Health Statistics, 1993.
5. Eriksson H. Heart failure: A growing public health problem. J Intern Med 1995;237:135-141.
6. Gurwitz JH. Suboptimal medication use in the elderly. The tip of the iceberg. JAMA 1994;272:316-317.
7. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med 1992;327:685-691.
8. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
9. Packer M. Therapeutic options in the management of chronic heart failure: Is there a drug of first choice? Circulation 1989;79:198-204.
10. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure: Veterans Administration Cooperative Vasodilator-Heart Failure Trial (V-HeFT II). N Engl J Med 1991;325:303-310.
11. McKelvie R, McConachie D, Yusuf S. Role of angiotensin enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur Heart J 1994;15(suppl B):9-13, 26-30.
12. Latini R, Maggioni AP, Flather M et al. ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials. Circulation 1995;92:3132-137.
13. Riegger GA. Lessons from recent randomized controlled trials for the management of congestive heart failure. Am J Cardiol 1993;71:38-40E.
14. Pfeffer MA, Braunwald E, Moye LA et al., on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
15. Guidelines for the evaluation and management of heart failure. American College of Cardiology/American Heart Association Task Force Report. Circulation 1995;92:2764-2784.
16. Konstam M, Dracup K, Baker D et al. Heart failure: Evaluation and care of patients with left ventricular systolic dysfunction. Clinical practice guideline No. 11. AHCPR Publication No. 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, June 1994. US Department of Health and Human Services.
17. Philbin EF, Andreau C, Rocco Jr. et al. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-838.
18. Krumholz HM, Wang Y, Parent EM et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997;157:2242-2247.
19. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized medicate patients in 10 large states. Arch Intern Med 1997;157:1103-1108.
20. Beery TA. Gender bias in the diagnosis and treatment of coronary artery disease. Heart Lung 1995;24:427-435.
21. Levy D, Larson MG, Vason RS et al. JAMA 1996;275:1557-1562.
22. Stafford RS, Saglam D, Blumentahl D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460-2464.
23. Massie BM, Kramer BL, Topic N. Lack of relationship between short-term hemodynamic effects of captopril and subsequent clinical responses. Circulation 1984;69:1135-1141.
24. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril. CONSENSUS Trial Study Group. Am J Cardiol 1992;70:479-487.
25. Taylor SH. Refocus on diuretics in the treatment of heart failure. Eur Heart J 1995;16 (suppl F):7-15.
26. Haque WA, Boehmer J, Clemson BS et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996;27:353-357.
27. Stanek EJ, Nara AR, Strohl KP et al. Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure. Pharmacotherapy 1994;14:321-329.
28. Mackenzie HS, Brenner BM. Current strategies for retarding progression of renal disease. Am J Kidney Dis 1998;31:161-170.
29. Packer M. Assessment and Treatment With Lisinopril and Survival (ATLAS). Recently presented data at the American College of Cardiology Scientific Session, Anaheim, CA, 1998.
30. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol 1996; 28:1323-1327.
31. Ray S, Dargie H. Infarct-related heart failure: The choice of ACE-inhibitor does not matter. Cardiovasc Drugs Ther 1994;8:433-436.
32. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines. J Am Coll Cardiol 1997;30:518-526.
33. Cleland JG. ACE-inhibitors for the prevention and treatment of heart failure: Why are they 'under-used'? J Hum Hypertens 1995;9:435-442.
34. Paul SD, Kuntz KM, Eagle KA, Weinstein NC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med 1994;154:1143-1149.